CRBP - Corbus Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CRBP is currently covered by 6 analysts with an average price target of $211.53. This is a potential upside of $195.99 (1261.2%) from yesterday's end of day stock price of $15.54.

Corbus Pharmaceuticals's activity chart (see below) currently has 39 price targets and 40 ratings on display. The stock rating distribution of CRBP is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 26.74% with an average time for these price targets to be met of 53.27 days.

Highest price target for CRBP is $32, Lowest price target is $32, average price target is $32.

Most recent stock forecast was given by GRAIG SUVANNAVEJH from MIZUHO on 20-May-2025. First documented stock forecast 13-Nov-2016.

Currently out of the existing stock ratings of CRBP, 8 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$32

$17.17 (115.78%)

$74

4 months 20 days ago
(20-May-2025)

0/2 (0%)

$24.59 (331.85%)

Buy

$82

5 months 4 days ago
(06-May-2025)

1/6 (16.67%)

$62.49 (320.30%)

154

Buy

$75

7 months ago
(10-Mar-2025)

1/1 (100%)

$8.1 (12.11%)

147

Buy

7 months 23 days ago
(17-Feb-2025)

2/5 (40%)

$61.01 (321.27%)

7

Buy

$40

$25.17 (169.72%)

$85

1 years 21 days ago
(19-Sep-2024)

0/2 (0%)

$20.49 (105.02%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CRBP (Corbus Pharmaceuticals) average time for price targets to be met?

On average it took 53.27 days on average for the stock forecasts to be realized with a an average price target met ratio 26.74

Which analyst has the current highest performing score on CRBP (Corbus Pharmaceuticals) with a proven track record?

JAMES EDWARDES JONES

Which analyst has the most public recommendations on CRBP (Corbus Pharmaceuticals)?

James Edwardes Jones works at RBC and has 0 price targets and 0 ratings on CRBP

Which analyst is the currently most bullish on CRBP (Corbus Pharmaceuticals)?

Christopher Marai with highest potential upside - $953.26

Which analyst is the currently most reserved on CRBP (Corbus Pharmaceuticals)?

James Edwardes Jones with lowest potential downside - -$13

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?